Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic
(World News Science)

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced an expansion of its computational design collaboration with Morphic Therapeutic (`Morphic`), a biotechnology company focused on developing a new class of oral small-molecule integrin-targeted therapeutics that Schrödinger co-founded with Harvard Professor Timothy Springer, Ph.D., and Polaris Partners. The expanded agreement, signed in May 2019, extends the partnership to discover and design therapeutic compounds leveraging Schrödinger´s ind ......